iBio
IBIO
#9813
Rank
NZ$81.82 M
Marketcap
NZ$3.64
Share price
15.07%
Change (1 day)
-10.64%
Change (1 year)

iBio (IBIO) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$14.03 Million

According to iBio's latest financial reports the company's total liabilities are NZ$14.03 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

iBio - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30NZ$12.14 M-71.15%
2023-06-30NZ$42.1 M-26.85%
2022-06-30NZ$57.56 M4.88%
2021-06-30NZ$54.88 M-5.79%
2020-06-30NZ$58.25 M39.24%
2019-06-30NZ$41.83 M5.25%
2018-06-30NZ$39.74 M7.4%
2017-06-30NZ$37 M-4.16%
2016-06-30NZ$38.61 M1975.02%
2015-06-30NZ$1.86 M312.82%
2014-06-30NZ$0.45 M-91.86%
2013-06-30NZ$5.53 M23.62%
2012-06-30NZ$4.48 M-48.01%
2011-06-30NZ$8.61 M54.68%
2010-06-30NZ$5.57 M558.9%
2009-06-30NZ$0.84 M-93.4%
2008-06-30NZ$12.81 M21.64%
2007-06-30NZ$10.53 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Genocea Biosciences
GNCA
NZ$45.64 M 225.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.51 B 10,724.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$196.27 B 1,398,852.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ$0.37 B 2,564.63%๐Ÿ‡บ๐Ÿ‡ธ USA